21 research outputs found
Le pharmacien hospitalier et la pratique clinique (comparaison française et québécoise au sein de deux hôpitaux pédiatriques)
No full textCette thèse est le fruit de trois années de résidence spécialisée effectuée au Québec. Il s agit d une évaluation comparative des pratiques professionnelles entre deux hôpitaux pédiatriques : l hôpital Robert Debré APHP, Paris, France et l hôpital Sainte-Justine, Montréal, Québec, Canada. Le contexte et la place de la pharmacie au sein des deux établissements sont décrits. Une évaluation transversale des pratiques de prise en charge de la douleur post-opératoire est réalisée. Enfin, l impact comparé de la présence de deux pharmaciens dans les services cliniques est exposé. Des propositions sont données sur les mesures permettant de faire progresser la pratique des pharmaciens en France vers une activité clinique, centrée sur une amélioration des soins donnés aux patients.This thesis is issued from a three-year specialised residency in Québec. This is a comparative evaluation of professional practices between two paediatric hospitals : Hôpital Robert Debré APHP, Paris, France and Hôpital Sainte-Justine, Montréal, Québec, Canada. The context and the role of pharmacy within the two hospitals are described. A transverse evaluation concerning surgical analgesia is carried out. Lastly, a comparison of the activity of two pharmacists in clinical wards is presented. Some key-points are proposed to improve French pharmacist clinical activities towards better patient care.PARIS-BIUP (751062107) / SudocSudocFranceF
Formes orales liquides en pédiatrie : quelles sont les causes des erreurs de reconstitution et d’administration ?
No full textInternational audienceLes formes orales liquides (FOLs), privilégiées en pédiatrie, permettent l’adaptation des doses au poids de l’enfant et d’éviter le risque de fausse route des formes orales solides grâce à leur facilité d’administration. Cependant, elles sont souvent responsables d’erreurs médicamenteuses lors de leur utilisation par les parents et les aidants, entraînant des erreurs de doses
Pharmaceutical care in an inpatient pediatric intensive care unit: an international multicentric study
No full textIntroduction Pediatric intensive care patient represent a population athigh risk for drug-related problems. Our objective is to describe drugrelated problems and intervention of four decentralized pharmacists inpediatric and cardiac intensive care unit.Materials & Methods Multicentric, descriptive and prospectivestudy over a six-month period (August 1st 2009-January 31st 2010).Drug-related problems and clinical interventions were compiled infour pediatric centers using a tool developed by the Socie´te´ Franc¸aisede Pharmacie Clinique. Data concerning patients, drugs, intervention,documentation, approval (if needed), and estimated impact werecompiled. The four pharmacists participating were from Belgium (B),France (F), Quebec (Q) and Switzerland (S).Results A total of 996 interventions were collected: 129 (13%) in B,238 (24%) in F, 278 (28%) in Q and 351 (35%) in S. These interventionstargeted 269 patients (median 22 month-old, 52% male): 69(26%) in B, 88 (33%) in F, 56 (21%) in Q and in S. These data werecollected during 28 non consecutive days in the clinical unit in B, 59days in F, 42 days in Q and 63 days in S. The main drug-relatedproblems were inappropriate administration technique (293, 29%),untreated indication (254, 25%) and supra therapeutic dosage (106,11%). The pharmacist's interventions concerned mainly administrationmode optimization (223, 22%), dose adjustment (200, 20%) andtherapeutic monitoring (164, 16%). The three major drug classesleading to interventions were anti-infectives for systemic use (233,23%) and alimentary tract and metabolism drugs (218, 22%). Interventionsconcerned mainly residents and all clinical staff (209, 21%).Among the 879 (88%) interventions requiring a physician's approval,731 (83%) were accepted. Interventions were considered as having amoderate (51%) or major (17%) clinical impact. Among the interventionsprovided, 10% were considered to have an economicalpositive impact. Differences and similarities between countries willbe presented at the poster session.Discussion & Conclusion Decentralized pharmacist at patient bedsideis a pre-requisite for pharmaceutical care. There are limitedstudies comparing the activity of clinical pharmacists betweencountries. This descriptive study illustrates the ability of clinicalpharmacist to identify and solve drug-related problems in pediatricintensive care unit in four different francophone countries
POPI; pédiatrie: Omissions et prescriptions inappropriées. Outil d'identification des prescriptions inappropriées chez l'enfant
No full text
Étude pilote sur la mise en place des soins pharmaceutiques dans le service de pédiatrie générale d'un hôpital français. Collaboration et comparaison franco-québécoise
No full textP297 - Entretien pharmaceutique à l’admission : Quel impact pour l’enfant traité par antiépileptiques ?
No full textLe plan pharmaceutique personnalisé et le nouveau modèle de pharmacie clinique
No full textInternational audienc
Pediatric drug-related problems: A multicenter study in four French-speaking countries
No full textBackground Pediatric intensive care patients represent a population at high risk for drug-related problems. There are few studies that compare the activity of clinical pharmacists between countries. Objective To describe the drug-related problems identified and interventions by four pharmacists in a pediatric cardiac and intensive care unit. Setting Four pediatric centers in France, Quebec, Switzerland and Belgium. Method This was a six-month multicenter, descriptive and prospective study conducted from August 1, 2009 to January 31, 2010. Drug-related problems and clinical interventions were compiled from four pediatric centers in France, Quebec, Switzerland and Belgium. Data on patients, drugs, intervention, documentation, approval and estimated impact were compiled. Main outcome measure Number and type of drug-related problems encountered in a large pediatric inpatient population. Results A total of 996 interventions were recorded: 238 (24 %) in France, 278 (28 %) in Quebec, 351 (35 %) in Switzerland and 129 (13 %) in Belgium. These interventions targeted 270 patients (median 21 months old, 53 % male): 88 (33 %) in France, 56 (21 %) in Quebec, 57 (21 %) in Switzerland and 69 (26 %) in Belgium. The main drug-related problems were inappropriate administration technique (29 %), untreated indication (25 %) and supra-therapeutic dose (11 %). The pharmacists' interventions were mostly optimizing the mode of administration (22 %), dose adjustment (20 %) and therapeutic monitoring (16 %). The two major drug classes that led to interventions were anti-infectives for systemic use (23 %) and digestive system and metabolism drugs (22 %). Interventions mainly involved residents and all clinical staff (21 %). Among the 878 (88 %) proposed interventions requiring physician approval, 860 (98 %) were accepted. Conclusion This descriptive study illustrates drug-related problems and the ability of clinical pharmacists to identify and resolve them in pediatric intensive care units in four French-speaking countries. © Springer Science+Business Media Dordrecht 2012
